Lockton：2026年全球医疗成本趋势报告（英文版）

Chronic conditions — including cardiovascular disease, cancer, diabetes, and musculoskeletal disorders — continue to be the leading contributors to medical claims worldwide. • Pharmacy costs and the expanded use of GLP-1 medications are emerging as significant cost drivers in markets where these medications are covered on the plan. • Utilization is rising due to the growing burden of disease and increased employee focus on health. • Poor plan usage and weak care management models are further